STOCK TITAN

PANAMERA HOLDINGS CORP 10-Q Filings

PHCI OTC Link

Every 10-Q that PANAMERA HOLDINGS CORP (PHCI) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow PHCI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PHCI filings page.

Rhea-AI Summary

Panamera Holdings Corporation reported a very large quarterly loss driven by a new technology license deal. For the six months ended January 31, 2026, the company recorded a net loss of $153,790,175, mainly from recognizing $153,400,000 of research and development expense on an acquired licensed carbon-conversion technology that was treated as in‑process R&D with no alternative future use.

By contrast, operating activity remains small: total revenues were $139,500 with gross profit of $84,600. Cash was only $17,061 and the working capital deficiency widened to $4,174,212, including a related‑party promissory note payable of $3,904,855 tied to the license fee. Accumulated deficit reached $177,094,294.

Management states that these conditions, combined with dependence on new debt or equity financing, raise substantial doubt about the company’s ability to continue as a going concern. The company is pursuing environmental and carbon-conversion opportunities under an exclusive U.S. and Mexico license with Rain Cage Carbon, Inc., but has minimal current revenues and significant related‑party obligations.

Rhea-AI Summary

Panamera Holdings Corporation reported a very large net loss of $153.7M for the quarter ended October 31, 2025, compared with a loss of $91k a year earlier. The loss came almost entirely from recognizing $153.4M of research and development expense tied to acquiring a licensed carbon-conversion technology.

The company generated no revenue in the quarter, versus $43.6k in prior-year sales of raw materials, and cash fell to $47.9k. Total assets declined to $113.6k, while a new related-party promissory note for the license left total liabilities at $4.1M and stockholders’ equity at a deficit of $(4.0M).

Management disclosed a working capital deficit of $3.4M and an accumulated deficit of $177.0M, concluding that these conditions raise substantial doubt about the company’s ability to continue as a going concern. The filing also notes material weaknesses in internal controls and a shareholder lawsuit over alleged share compensation, which the company disputes.